Ensuring Value for Money in Health Care: The Role of Health Technology Assessment in the European UnionWHO Regional Office Europe, 2008 - Всего страниц: 156 This book provides a detailed review of the role of health technology assessment (HTA) in the European Union. It examines both method and process in the prioritization and financing of modern health care and presents extensive case studies from Sweden, the Netherlands, Finland, France, Germany and the United Kingdom. The book examines a number of issues, with particular emphasis on the responsibility and membership of HTA bodies' assessment procedures and methods, the application of HTA evidence to decision-making, and the dissemination and implementation of findings. It aims to highlight ways to improve the HTA process in Europe by examining key challenges and identifying opportunities to support value and innovation in health care. It will be vital reading for a wide range of stakeholders including policy-makers, HTA bodies, manufacturers, health-care professionals and patient organizations. |
Часто встречающиеся слова и выражения
analysis Anell Assessment in Health assessment process Bellanger Board Busse Carlsson Centre Clinical Excellence Cochrane Collaboration collaboration cost-utility analysis costs countries criteria DAHTA decision-making process decisions disease drugs economic evaluation effectiveness evidence-based evidence-based medicine experts Finland FinOHTA funds groups Health Council health economic health insurance Health Systems Health Technology Assessment health-care system HTA activities HTA bodies HTA governance HTA process HTA results HTA’s impact implementation innovation International Journal interventions IQWiG Journal of Health manufacturers medical devices medicines methodological methods Ministry of Health Moreover National Netherlands NICE guidance OECD organizations outcome patient pharmaceuticals pharmacoeconomic positive list priorities priority-setting procedures programmes public health QALY recommendations reimbursement and pricing relevant reports responsible review bodies scientific social stakeholders Sweden systematic reviews technology appraisals therapy topic selection transparency treatment typically United Kingdom Zentner Zentner et al